Tag: GLP-1 drugs

Altcoins

Eli Lilly Emerges as Top Growth Stock Pick

Jim Cramer boldly calls one pharma giant the absolute greatest growth stock right now, with another solid contender close behind....

06/02/2026

3 views

Read More

Market News

Hims Stock Drops on FDA Warning Over Copycat GLP-1 Drugs

Hims shares just took a major hit after the FDA signaled a crackdown on cheap copycat versions of popular GLP-1...

06/02/2026

3 views

Read More

Stocks

Eli Lilly Surges Ahead in GLP-1 Market as Novo Faces 2026 Decline

While both giants face U.S. pricing squeezes on weight-loss drugs, Eli Lilly just forecasted massive 2026 growth while Novo Nordisk...

04/02/2026

4 views

Read More

Growth Picks

Eli Lilly Stock Surges After Massive GLP-1 Earnings Beat

Eli Lilly just posted mind-blowing Q4 numbers thanks to its GLP-1 powerhouses — revenue jumped 43%, profits soared, and guidance...

04/02/2026

3 views

Read More

Market News

Market Concerns Hit Lilly Earnings, Housing Shows Optimism

Markets sent Eli Lilly shares sliding ahead of earnings after a major rival issued grim guidance—but housing stocks quietly perked...

03/02/2026

2 views

Read More

Market News

Structure Therapeutics CEO on Next-Gen Obesity Pill Revolution

The obesity treatment landscape is shifting fast with oral GLP-1 pills entering the scene. Structure Therapeutics' CEO shares why their...

21/01/2026

2 views

Read More

Market News

Drug Stocks Poised for Major Gains in 2026

After years of tech dominating portfolios, a quiet revolution in healthcare is brewing. Conversations with top CEOs reveal massive untapped...

18/01/2026

5 views

Read More

Market News

Novo Nordisk Shares Soar on Promising Wegovy Pill Launch

Novo Nordisk's stock jumped after the Wegovy pill's launch showed solid early demand with thousands of prescriptions. Is this the...

16/01/2026

2 views

Read More

Altcoins

Planet Fitness Stock Boost From Weight Loss Drugs

As more people turn to weight-loss medications, one gym chain could see a major membership surge. Analysts are bullish on...

16/01/2026

2 views

Read More

Altcoins

Novo Nordisk GLP-1 Pill: Pricing Pressures & 2026 Outlook

At JPMorgan 2026, Novo Nordisk's CEO warned of major price pressure on GLP-1 drugs this year, even as their new...

14/01/2026

4 views

Read More